OrbusNeich files patent infringement lawsuits in Germany and the Netherlands against rival stent-maker Boston Scientific, riding on momentum from a recent win from the European Patent Office.
OrbusNeich is taking a recent patent infringement win against Boston Scientific (NYSE:BSX) even further, filing lawsuits in both Germany and the Netherlands to allege patent infringement over stent technology.
OrbusNeich claims Boston Scientific’s Promus Element, Promus Element Plus, Taxus, and other stents are infringing on a pair of patents, for which OrbusNeich is seeking a preliminary injunction, damages, and a recall of the infringing products that have not been used in patients.